Abstract
Over the past 60 years, a large number of selective neurotoxins were discovered and developed, making it possible to animal-model a broad range of human neuropsychiatric and neurodevelopmental disorders. In this paper, we highlight those neurotoxins that are most commonly used as neuroteratologic agents, to either produce lifelong destruction of neurons of a particular phenotype, or a group of neurons linked by a specific class of transporter proteins (i.e., dopamine transporter) or body of receptors for a specific neurotransmitter (i.e., NMDA class of glutamate receptors). Actions of a range of neurotoxins are described: 6-hydroxydopamine (6-OHDA), 6-hydroxydopa, DSP-4, MPTP, methamphetamine, IgG-saporin, domoate, NMDA receptor antagonists, and valproate. Their neuroteratologic features are outlined, as well as those of nerve growth factor, epidermal growth factor, and that of stress. The value of each of these neurotoxins in animal modeling of human neurologic, neurodegenerative, and neuropsychiatric disorders is discussed in terms of the respective value as well as limitations of the derived animal model. Neuroteratologic agents have proven to be of immense importance for understanding how associated neural systems in human neural disorders may be better targeted by new therapeutic agents.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbruzzese G, Marchese R, Avanzino L, Pelosin E (2015) Rehabilitation for Parkinson’s disease: Current outlook and future challenges. Parkinsonism Relat Disord pii:S1353-8020(15)00380-6
Abe Y, Namba H, Zheng Y, Nawa H (2009) In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 161(1):95–110
Abel TJ, Dalm BD, Grossbach AJ, Jackson AW, Thomsen T, Greenlee JD (2014) Lateralized effect of pallidal stimulation on self-mutilation in Lesch-Nyhan disease. J Neurosurg Pediatr 14(6):594–597
Ago M, Ago K, Hara K, Kashimura S, Ogata M (2006) Toxicological and histopathological analysis of a patient who died nine days after a single intravenous dose of methamphetamine: a case report. Leg Med (Tokyo) 8(4):235–239
Allison DJ, Ditor DS (2015) Targeting inflammation to influence mood following spinal cord injury: a randomized clinical trial. J Neuroinflammation 12(1):204
Ananth C, Thameem Dheen S, Gopalakrishnakone P, Kaur C (2001) Domoic acid-induced neuronal damage in the rat hippocampus: changes in apoptosis related genes (bcl-2, bax, caspase-3) and microglial response. J Neurosci Res 66(2):177–190
Ananth C, Gopalakrishnakone P, Kaur C (2003) Induction of inducible nitric oxide synthase expression in activated microglia following domoic acid (DA)-induced neurotoxicity in the rat hippocampus. Neurosci Lett 338(1):49–52
Anastasio NC, Johnson KM (2008) Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups. Pharmacol Biochem Behav 90(4):569–577
Antonini TN, Becker SP, Tamm L, Epstein JN (2015) Hot and cool executive functions in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Int Neuropsychol Soc 21(8):584–595
Archer T (2011) Physical exercise alleviates debilities of normal aging and Alzheimer’s disease. Acta Neurol Scand 123:221–238
Archer T (2012) Influence of physical exercise on traumatic brain injury deficits: scaffolding effect. Neurotox Res 21(4):418–434
Archer T (2014) Health benefits of physical exercise for children and adolescents. J Novel PysioTher 4:203
Archer T (2015) Physical exercise as an epigenetic factor determining behavioral outcomes. Clin Exp Psychol 1:1
Archer T (2016a) NMDA-R blockers and ADHD modeling, In: Kostrzewa RM, Archer T (eds.) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Archer T (2016b) Noradrenergic-dopaminergic interactions due to DSP4—MPTP neurotoxin treatments: iron connection. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Archer T, Fredriksson A (2006) Influence of noradrenaline denervation on MPTP-induced deficits in mice. J Neural Transm (Vienna) 113(9):1119–1129
Archer T, Fredriksson A (2010) Physical exercise attenuates MPTP-induced deficits in mice. Neurotox Res 18(3–4):313–327
Archer T, Fredriksson A (2012) Delayed exercise-induced functional and neurochemical partial restoration following MPTP. Neurotox Res 21(2):210–221
Archer T, Fredriksson A (2013) The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice. Neurotox Res 24(3):393–406
Archer T, Garcia D (2015) Exercise and dietary restriction for promotion of neurohealth benefits. Health 7:136–152
Archer T, Garcia D (2016) Attention-deficit/hyperactive disorder: focus upon aberrant N-methyl-D-aspartate receptor systems. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Archer T, Kostrzewa RM (2012) Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory. Neurotox Res 21(2):195–209
Archer T, Kostrzewa RM (2016) Exercise and nutritional benefits in PD: rodent models and clinical settings. In: Kostrzewa RM, Archer T (eds) Neurotoxin Modeling of Brain Disorders-Lifelong Outcomes in Behavioral Teratology. Springer, New York
Archer T, Fredriksson A, Johansson B (2011a) Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol Scand 123(2):73–84
Archer T, Fredriksson A, Schütz E, Kostrzewa RM (2011b) Influence of physical exercise on neuroimmunological functioning and health: aging and stress. Neurotox Res 20(1):69–83
Archer T, Garcia D, Fredriksson A (2014a) Restoration of MPTP-induced deficits by exercise and Milmed(®) co-treatment. PeerJ 2:e531
Archer T, Josefsson T, Lindwall M (2014b) Effects of physical exercise on depressive symptoms and biomarkers in depression. CNS Neurol Disord: Drug Targets 13(10):1640–1653
Arsenault D, Coulombe K, Zhu A, Gong C, Kil KE, Choi JK, Poutiainen P, Brownell AL (2015) Loss of metabotropic glutamate receptor 5 function on peripheral benzodiazepine receptor in mice prenatally exposed to LPS. PLoS One 10(11):e0142093
Ashok A, Rai NK, Tripathi S, Bandyopadhyay S (2015) Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol Sci 143(1):64–80
Babenko O, Kovalchuk I, Metz GA (2015) Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev 48:70–91
Baldi I, Gruber A, Rondeau V, Lebailly P, Brochard P, Fabrigoule C (2011) Neurobehavioral effects of long-term exposure to pesticides: results from the 4-year follow-up of the PHYTONER study. Occup Environ Med 68(2):108–115
Banerjee S, Riordan M, Bhat MA (2014) Genetic aspects of autism spectrum disorders: insights from animal models. Front Cell Neurosci 8:58
Barker DJ (2007) The origins of the developmental origins theory. J Intern Med 261(5):412–417. Review
Barnes SA, Sawiak SJ, Caprioli D, Jupp B, Buonincontri G, Mar AC, Harte MK, Fletcher PC, Robbins TW, Neill JC, Dalley JW (2015) Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia. Int J Neuropsychopharmacol 18(2). pii: pyu010. doi: 10.1093/ijnp/pyu010
Barra R, Cruz G, Mayerhofer A, Paredes A, Lara HE (2014) Maternal sympathetic stress impairs follicular development and puberty of the offspring. Reproduction 148(2):137–145
Basta-Kaim A, Fijał K, Ślusarczyk J, Trojan E, Głombik K, Budziszewska B, Leśkiewicz M, Regulska M, Kubera M, Lasoń W, Wędzony K (2015) Prenatal administration of liposaccharide induces sex-dependent changes in glutamic acid decarboxylase and parvalbumin in the adult rat brain. Neuroscience 287:78–92
Ben-Ari Y, Khazipov R, Leinekugel X, Caillard O, Gaiarsa JL (1997) GABAA, NMDA and AMPA receptors: a developmentally regulated ‘ménage à trois’. Trends Neurosci 20(11):523–529. Review
Berger TW, Kaul S, Stricker EM, Zigmond MJ (1985) Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res 336(2):354–358
Berkowitz BA, Spector S, Brossi A, Focella A, Teitel S (1970) Preparation and biological properties of (-) and (+)-6-hydroxydopa. Experientia 26(9):982–983
Bernard PB, MacDonald DS, Gill DA, Ryan CL, Tasker RA (2007) Hippocampal mossy fiber sprouting and elevated trkB receptor expression following systemic administration of low dose domoic acid during neonatal development. Hippocampus 17:1121–1133
Bezard E, Yue Z, Kirik D, Spillantini MG (2013) Animal models of Parkinson’s disease: limits and relevance to neuroprotection studies. 28(1):61–70
Bihaqi SW, Zawia NH (2013) Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). Neurotoxicology 39:95–101
Bihaqi SW, Bahmani A, Adem A, Zawia NH (2014) Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: relevance to AD. Neurotoxicology 44:114–120
Birch AM (2014) The contribution of astrocytes to Alzheimer’s disease. Biochem Soc Trans 42(5):1316–1320
Bisagno V, Cadet JL (2014) Methamphetamine and MDMA neurotoxicity: biochemical and molecular mechanisms. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer New York, pp 219–236. ISBN 978-1-4614-5835-7 (print); ISBN 978-1-4614-5836-4 (eBook); ISBN 978-1-4614-7458-6 (print and electronic bundle). doi:10.1007/978-1-4614-5836-4_75
Bolin CM, Basha R, Cox D, Zawia NH, Maloney B, Lahiri DK, Cardozo-Pelaez F (2006) Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J 20(6):788–790
Bortel A (2014) Nature of DSP-4 neurotoxicity. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 347–363. ISBN 978-1-4614-5835-7 (print); ISBN 978-1-4614-5836-4 (eBook); ISBN 978-1-4614-7458-6 (print and electronic bundle). doi:10.1007/978-1-4614-5836-4_80
Bortel A, Słomian L, Nitka D, Swierszcz M, Jaksz M, Adamus-Sitkiewicz B, Nowak P, Jośko J, Kostrzewa RM, Brus R (2008) Neonatal N-(-2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) treatment modifies the vulnerability to phenobarbital- and ethanol-evoked sedative-hypnotic effects in adult rats. Pharmacol Rep 60:331–338
Bowyer JF, Frame LT, Clausing P, Nagamoto-Combs K, Osterhout CA, Sterling CR, Tank AW (1998) Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. J Pharmacol Exp Ther 286(2):1074–1085
Bracci-Laudiero L, De Stefano ME (2016) NGF in early embryogenesis, differentiation and pathology in the nervous and immune systems. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Mueller RA (1984a) Neonatal-6-hydroxydopamine treatment: model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacol Biochem Behav 21(3):459–461
Breese GR, Baumeister AA, McCown TJ, Emerick SG, Frye GD, Crotty K, Mueller RA (1984b) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J Pharmacol Exp Ther 231(2):343–354
Breese GR, Baumeister A, Napier TC, Frye GD, Mueller RA (1985a) Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J Pharmacol Exp Ther 235(2):287–295
Breese GR, Napier TC, Mueller RA (1985b) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats. J Pharmacol Exp Ther 234(2):447–455
Breese GR, Mueller RA, Napier TC, Duncan GE (1986) Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease. Adv Exp Med Biol 204:197–215
Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA (1987) 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J Pharmacol Exp Ther 240(1):167–176
Breese GR, Criswell HE, Duncan GE, Mueller RA (1989) Dopamine deficiency in self-injurious behavior. Psychopharmacol Bull 25(3):353–357. Review. Erratum in: Psychopharmacol Bull 1990; 26(3):296
Breese GR, Criswell HE, Duncan GE, Mueller RA (1990a) A dopamine deficiency model of Lesch-Nyhan disease—the neonatal-6-OHDA-lesioned rat. Brain Res Bull 25(3):477–484. Review
Breese GR, Criswell HE, Mueller RA (1990b) Evidence that lack of brain dopamine during development can increase the susceptibility for aggression and self-injurious behavior by influencing D1-dopamine receptor function. Prog Neuropsychopharmacol Biol Psychiatry 14(Suppl):S65–S80
Breese GR, Criswell HE, Johnson KB, O’Callaghan JP, Duncan GE, Jensen KF, Simson PE, Mueller RA (1994) Neonatal destruction of dopaminergic neurons. Neurotoxicology 15(1):149–159
Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL (2005) The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Brain Res Rev 48(1):57–73
Broberg BV, Dias R, Glenthøj BY, Olsen CK (2008) Evaluation of a neurodevelopmental model of schizophrenia—early postnatal PCP treatment in attentional set-shifting. Behav Brain Res 190(1):160–163
Broberg BV, Oranje B, Glenthøj BY, Fejgin K, Plath N, Bastlund JF (2010) Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia—gating of auditory-evoked potentials and prepulse inhibition. Behav Brain Res 213(2):142–147
Broberg BV, Madsen KH, Plath N, Olsen CK, Glenthøj BY, Paulson OB, Bjelke B, Søgaard LV (2013) A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by magnetic resonance imaging. Behav Brain Res 250:1–8
Brown RW, Peterson DJ (2016) Applications of the neonatal quinpirole model to psychosis and convergence upon the dopamine D2 receptor. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Brown GC, Vilalta A (2015) How microglia kill neurons. Brain Res 1628(Pt B):288–297
Brown RW, Gass JT, Kostrzewa RM (2002) Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats. Pharmacol Biochem Behav 72(3):591–600
Brown RW, Flanigan TJ, Thompson KN, Thacker SK, Schaefer TL, Williams MT (2004a) Neonatal quinpirole treatment impairs Morris water task performance in early postweanling rats: relationship to increases in corticosterone and decreases in neurotrophic factors. Biol Psychiatry 56(3):161–168
Brown RW, Thompson KD, Thompson KN, Ward JJ, Thacker SK, Williams MT, Kostrzewa RM (2004b) Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression. Eur J Neurosci 19(6):1634–1642
Brown RW, Thompson KN, Click IA, Best RA, Thacker SK, Perna MK (2005) The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole. Psychopharmacology 180(2):234–240
Brown RW, Perna MK, Schaefer TL, Williams MT (2006) The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole. Synapse 59(5):253–259
Brown RW, Perna MK, Maple AM, Wilson TD, Miller BE (2008) Adulthood olanzapine treatment fails to alleviate decreases of ChAT and BDNF RNA expression in rats quinpirole-primed as neonates. Brain Res 1200:66–77
Brown RW, Maple AM, Perna MK, Sheppard AB, Cope ZA, Kostrzewa RM (2012) Schizophrenia and substance abuse comorbidity: nicotine addiction and theneonatal quinpirole model. Dev Neurosci 34(2–3):140–151
Brundin L, Erhardt S, Bryleva EY, Achtyes ED, Postolache TT (2015) The role of inflammation in suicidal behaviour. Acta Psychiatr Scand 132(3):192–203
Brus R, Szkilnik R, Nowak P, Kasperska A, Oświęcimska J, Kostrzewa RM, Shani J (1998a) Locomotor sensitization of dopamine receptors by their agonists quinpirole and SKF-38393, during maturation and aging in rats. Pharmacol Rev Commun 10:25–30
Brus R, Szkilnik R, Nowak P, Kostrzewa RM, Shani J (1998b) Sensitivity of central dopamine receptors in rats to quinpirole and SKF-38393, administered at their early stages of ontogenicity, evaluated by learning and memorizing a conditioned avoidance reflex. Pharmacol Rev Commun 10:31–36
Brus R, Nowak P, Szkilnik R, Mikolajun U, Kostrzewa RM (2004) Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox Res 6(4):317–325
Budni J, Bellettini-Santos T, Mina F, Garcez ML, Zugno AI (2015) The involvement of BDNF, NGF and GDNF in aging and Alzheimer’s disease. Aging Dis 6(5):331–341
Byrnes KR, Stoica B, Loane DJ, Riccio A, Davis MI, Faden A (2009) Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 57(5):550–560
Cadet JL (2014) Epigenetics of stress, addiction, and resilience: Therapeutic implications. Mol Neurobiol. 53(1):545–560
Cadet JL, Jayanthi S (2013) Epigenetics of methamphetamine-induced changes in glutamate function. Neuropsychopharmacology 38(1):248–249
Casey DE (1987) Tardive dyskinesia. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1411–1419
Castañé A, Santana N, Artigas F (2015) PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Psychopharmacology 232(21–22):4085–4097
Chen J, Wang Z, Li M (2011) Multiple ‘hits’ during postnatal and early adulthood periods disrupt the normal development of sensorimotor gating ability in rats. J Psychopharmacol 25(3):379–392
Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET, Pedersen LH, Vestergaard M (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309(16):1696–1703
Christianson AL, Chester N, Kromberg JG (1994) Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 36:361–369
Chung WS, Welsh CA, Barres BA, Stevens B (2015) Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci 18(11):1539–1545
Clark MB, King JC, Kostrzewa RM (1979) Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa. Neurosci Lett 13(3):331–336
Cohen G, Heikkila RE (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249(8):2447–2452
Cooper JD, Lindholm D, Sofroniew MV (1994) Reduced transport of 125I-NGF by cholinergic neurons and downregulated TrkA expression in the medial septum of aged rats. Neuroscience 62:625–629
Cope ZA, Huggins KN, Sheppard AB, Noel DM, Roane DS, Brown RW (2010) Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood. Synapse 64(4):289–300
Cordova FM, Aguiar AS Jr, Peres TV, Lopes MW, Gonçalves FM, Remor AP, Lopes SC, Pilati C, Latini AS, Prediger RD, Erikson KM, Aschner M (2012) Leal RB (2012) In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS One 7(3):e33057
Criswell H, Mueller RA, Breese GR (1989) Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J Neurosci 9(1):125–133
Dabrowska J, Nowak P, Brus R (2007) Desensitization of 5-HT(1A) autoreceptors induced by neonatal DSP-4 treatment. Eur Neuropsychopharmacol 17:129–137
Dal-Pizzol F, Klamt F, Frota ML Jr, Andrades ME, Caregnato FF, Vianna MM, Schröder N, Quevedo J, Izquierdo I, Archer T, Moreira JC (2001) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Brain Res Dev Brain Res 130(1):109–114
De Bartolo P, Gelfo F, Mandolesi L, Foti F, Cutuli D, Petrosini L (2009) Effects of chronic donepezil treatment and cholinergic deafferentation on parietal pyramidal neuron morphology. J Alzheimers Dis 17(1):177–191
De Bartolo P, Cutuli D, Ricceri L, Gelfo F, Foti F, Laricchiuta D, Scattoni ML, Calamandrei G, Petrosini L (2010) Does age matter? Behavioral and neuro-anatomical effects of neonatal and adult basal forebrain cholinergic lesions. J Alzheimers Dis 20(1):207–227
de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, Camí J (2000) Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans. Br J Clin Pharmacol 49(2):104–109
De-Carolis C, Boyd GA, Mancinelli L, Pagano S, Eramo S (2015) Methamphetamine abuse and “meth mouth” in Europe. Med Oral Patol Oral Cir Bucal 20(2):e205–e210
Delany FM, Byrne ML, Whittle S, Simmons JG, Olsson C, Mundy LK, Patton GC, Allen NB (2015) Depression, immune function, and early adrenarche in children. Psychoneuroendocrinology 63:228–234
Desplats P, Dumaop W, Cronin P, Gianella S, Woods S, Letendre S, Smith D, Masliah E, Grant I (2014) Epigenetic alterations in the brain associated with HIV-1 infection andmethamphetamine dependence. PLoS One 9(7):e102555
Do HT, Bruelle C, Pham DD, Jauhiainen M, Eriksson O, Korhonen LT, Lindholm D (2015) Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth. J Neurochem 2015 Oct 20. doi:10.1111/jnc.13397. [Epub ahead of print]
Doebel S, Zelazo PD (2013) Bottom-up and top-down dynamics in young children’s executive function: Labels aid 3-year-olds’ performance on the Dimensional Change Card Sort. Cogn Dev 28(3):222–232
Doucette TA, Tasker RA (2016) Perinatal domoic acid as a neuroteratogen. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Doucette TA, Strain SM, Allen GV, Ryan CL, Tasker RAR (2000) Comparative behavioural toxicity of domoic acid and kainic acid in neonatal rats. Neurotoxicol Teratol 22:863–869
Doucette TA, Bernard PB, Husum H, Perry MA, Ryan CL, Tasker RA (2004) Low doses of domoic acid during postnatal development produce permanent changes in rat behaviour and hippocampal morphology. Neurotox Res 6(7,8):555–563
Fialová M, Šírová J, Bubeníková-Valešová V, Šlamberová R (2015) The effect of prenatal methamphetamine exposure on recognition memory in adult rats. Prague Med Rep 116(1):31–39
Fornai F, Bassi L, Bonaccorsi I, Giorgi F, Corsini GU (1997) Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents. Funct Neurol 12(3–4):193–198
Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol 159(1):25–30
Fredriksson A, Schröder N, Eriksson P, Izquierdo I, Archer T (2000) Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res Dev Brain Res 119(1):65–74
Fredriksson A, Stigsdotter IM, Hurtig A, Ewalds-Kvist B, Archer T (2011) Running wheel activity restores MPTP-induced functional deficits. J Neural Transm 118(3):407–420
Fu R, Sutcliffe D, Zhao H, Huang X, Schretlen DJ, Benkovic S, Jinnah HA (2015) Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways. Mol Genet Metab 114(1):55–61
Fukushima S, Furube E, Itoh M, Nakashima T, Miyata S (2015) Robust increase in microglia proliferation in the fornix of hippocampal axonal pathway after single LPS stimulation. J Neuroimmunol 285:31–40
Furukawa S (2015) Basic research on neurotrophic factors and its application to medical uses. Yakugaku Zasshi 135(11):1213–1226
Futamura T, Kakita A, Tohmi M, Sotoyama H, Takahashi H, Nawa H (2003) Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol Psychiatry 8(1):19–29
Galbally M, Roberts M, Buist A; Perinatal Psychotropic Review Group (2010) Mood stabilizers in pregnancy: a systematic review. Aust NZJ Psychiatry 44(11):967–977
Gao Y, Liu L, Li Q, Wang Y (2015) Differential alterations in the morphology and electrophysiology of layer II pyramidal cells in the primary visual cortex of a mouse model prenatally exposed to LPS. Neurosci Lett 591:138–143
Gill DA, Ramsay R, Tasker RA (2010) Selective reductions in subpopulations of GABAergic neurons in a developmental rat model of epilepsy. Brain Res 1331:114–123
Godino A, Jayanthi S, Cadet JL (2015) Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Epigenetics 10(7):574–580
Gong L, Kostrzewa RM, Fuller RW, Perry KW (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 261:1000–1007
Gong L, Kostrzewa RM, Brus R, Fuller RW, Perry KW (1993a) Ontogenetic SKF 38393 treatments sensitize dopamine D1 receptors in neonatal 6-OHDA-lesioned rats. Brain Res Dev Brain Res 76(1):59–65
Gong L, Kostrzewa RM, Perry KW, Fuller RW (1993b) Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Brain Res Dev Brain Res 76(2):233–238
Gong L, Kostrzewa RM, Li C (1994) Neonatal 6-OHDA and adult SKF 38393 treatments alter dopamine D1 receptor mRNA levels: absence of other neurochemical associations with the enhanced behavioral responses of lesioned rats. J Neurochem 63:1282–1290
Göttle M, Prudente CN, Fu R, Sutcliffe D, Pang H, Cooper D, Veledar E, Glass JD (2014) Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease. Ann Neurol 76(1):95–107
Grados M, Sung HM, Kim S, Srivastava S (2014) Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development. Drug Dev Res 75(6):372–383
Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR, Williams MT, Vorhees CV (2013) Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol 16(2):377–391
Grayson DR, Guidotti A (2015) Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder. Epigenomics. 2015 Nov 9. [Epub ahead of print] PMID: 26551091
Grayson B, Barnes SA, Markou A, Piercy C, Podda G, Neill JC (2016) Postnatal phencyclidine (PCP) as a neurodevelopmental model of schizophrenia pathophysiology and symptpmatology: a review. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Groves NJ, McGrath JJ, Burne TH (2014) Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr 34:117–141
Hamdi A, Kostrzewa RM (1991) Ontogenic homologous supersensitization of dopamine D1 receptors. Eur J Pharmacol 203:115–120
Harro J (2015) Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol 120:179–204
Hasan W, Smith PG (2014) Decreased adrenoceptor stimulation in heart failure rats reduces NGF expression by cardiac parasympathetic neurons. Auton Neurosci 181:13–20
He N, Li F, Li Y, Guo L, Chen L, Huang X, Lui S, Gong Q (2015) Neuroanatomical deficits correlate with executive dysfunction in boys with attention deficit hyperactivity disorder. Neurosci Lett 600:45–49
Hertz L, Chen Y, Waagepetersen HS (2015) Effects of ketone bodies in Alzheimer’s disease in relation to neural hypometabolism, β-amyloid toxicity and astrocyte function. J Neurochem 134(1):7–20
Hirsch MA, Iyer SS, Sanjak M (2015) Exercise-induced neuroplasticity in human Parkinson’s disease: what is the evidence telling us? Parkinsonism Relat Disord 22(Suppl 1):S78–S81
Hoftman GD, Lewis DA (2011) Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull 37(3):493–503
Hohsfield LA, Ehrlich D, Humpel C (2014) Intravenous infusion of nerve growth factor-secreting monocytes supports the survival of cholinergic neurons in the nucleus basalis of Meynert in hypercholesterolemia Brown-Norway rats. J Neurosci Res 92(3):298–306
Holmes GL, Sarkisian M, Ben-Ari Y, Chevassus-Au-Louis N (1999) Mossy fiber sprouting after recurrent seizures during early development in rats. J Comp Neurol 22:537–553
Hongwanishkul D, Happaney KR, Lee WS, Zelazo PD (2006) Assessment of hot and cool executive function in young children: age-related changes and individual differences. Dev Neuropsychol 28(2):617–644
Hrebíčková I, Malinová-Ševčíková M, Macúchová E, Nohejlová K, Šlamberová R (2014) Exposure to methamphetamine during first and second half of prenatal period and its consequences on cognition after long-term application in adulthood. Physiol Res 63(Suppl 4):S535–S545
Huang N-Y, Kostrzewa RM, Li C, Perry KW, Fuller RW (1997) Increased spontaneous oral dyskinesias persist in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates. J Pharmacol Exp Ther 280:268–276
Ibi D, González-Maeso J (2015) Epigenetic signaling in schizophrenia. Cell Signal 27(10):2131–2136
Iulita MF, Cuello AC (2014) Nerve growth factor metabolic dysfunction in Alzheimer’s disease and Down syndrome. Trends Pharmacol Sci 35(7):338–348
Iwakura Y, Zheng Y, Sibilia M, Abe Y, Piao YS, Yokomaku D, Wang R, Ishizuka Y, Takei N, Nawa H (2011a) Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1). J Neurochem 118(1):45–56
Iwakura Y, Wang R, Abe Y, Piao YS, Shishido Y, Higashiyama S, Takei N, Nawa H (2011b) Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2). J Neurochem 118(1):57–68
Jablonski SA, Williams MT, Vorhees CV (2016) Neurobehavioral effects from developmental methamphetamine exposure. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Jacobowitz D, Kostrzewa R (1971) Selective action of 6-hydroxydopa on noradrenergic terminals: mapping of preterminal axons of the brain. Life Sci I 10(23):1329–1342
Jacobsen PE, Henriksen TB, Haubek D, Østergaard JR (2014) Prenatal exposure to antiepileptic drugs and dental agenesis. PLoS One 9(1):e84420
Jain P, Wadhwa PK, Jadhav HR (2015) Reactive astrogliosis: role in Alzheimer’s disease. CNS Neurol Disord Drug Targets 14(7):872–879
Jeste DV, Caligiuri MP (1993) Tardive dyskinesia. Schizophr Bull 19:303–315
Jinnah HA, Jones MD, Wojcik BE, Rothstein JD, Hess EJ, Friedmann T, Breese GR (1999) Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 72(1):225–229
Jo WK, Zhang Y, Emrich HM, Dietrich DE (2015) Glia in the cytokine-mediated onset of depression: fine tuning the immune response. Front Cell Neurosci 9:268
Jonsson G, Hallman H, Ponzio F, Ross S (1981) DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 72:173–188
Jonsson G, Hallman H, Sundström E (1982) Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat. Neuroscience 7(11):2895–2907
Kaalund SS, Riise J, Broberg BV, Fabricius K, Karlsen AS, Secher T, Plath N, Pakkenberg B (2013) Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats. J Neurochem 124(4):548–557
Kato T, Abe Y, Sotoyama H, Kakita A, Kominami R, Hirokawa S, Ozaki M, Takahashi H, Nawa H (2011) Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol Psychiatry 16(3):307–320
Kehoe P, Callahan M, Daigle A, Mallinson K, Brudzynski S (2001) The effect of cholinergic stimulation on rat pup ultrasonic vocalizations. Dev Psychobiol 38(2):92–100
Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP (2015) Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci 9:392
Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, Shin CY, Ko KH (2011) The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett 201(2):137–142
Kim JW, Seung H, Kwon KJ, Ko MJ, Lee EJ, Oh HA, Choi CS, Kim KC, Gonzales EL, You JS, Choi DH, Lee J, Han SH, Yang SM, Cheong JH, Shin CY, Bahn GH (2014) Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behaviour in valproic acid-induced animal model of autism. PLoS One 9(8):e104927
Kirsten TB, Lippi LL, Bevilacqua E, Bernardi MM (2013) LPS exposure increases maternal corticosterone levels, causes placental injury and increases Il-1B levels in adult rat offspring: relevance to autism. PLoS One 8(12):e82244
Kjaerby C, Bundgaard C, Fejgin K, Kristiansen U, Dalby NO (2013) Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment. Neuropharmacology 72:157–168
Kjaerby C, Broberg BV, Kristiansen U, Dalby NO (2014) Impaired GABAergic inhibition in the prefrontal cortex of early postnatalphencyclidine (PCP)-treated rats. Cereb Cortex 24(9):2522–2532
Knapp DJ, Breese GR (2016) Perinatal 6-hydroxydopamine to produce a rodent model of Lesch-Nyhan disease. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Kokoshka JM, Metzger RR, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE (1998) Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res 799(1):78–83
Kostrzewa RM (1988) Reorganization of noradrenergic neuronal systems following neonatal chemical and surgical injury. Prog Brain Res 73:405–423. Review
Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19:1–17
Kostrzewa RM (2016) Perinatal effects of 6-hydroxydopa, a noradrenergic neurotoxin and AMPA receptor excitotoxin. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Kostrzewa RM, Brus R (1991) Ontogenic homologous supersensitization of quinpirole-induced yawning in rats. Pharmacol Biochem Behav 39:517–519
Kostrzewa RM, Brus R (2016) Lifelong rodent model of tardive dyskinesia-persistence after antipsychotic drug withdrawal. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Kostrzewa RM, Garey RE (1976) Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain. J Pharmacol Exp Ther 197:105–118
Kostrzewa RM, Garey RE (1977) Sprouting of noradrenergic terminals in rat cerebellum following neonatal treatment with 6-hydroxydopa. Brain Res 124:385–391
Kostrzewa RM, Gong L (1991) Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Pharmacol Biochem Behav 39(3):677–682
Kostrzewa RM, Harper JW (1974) Effect of 6-hydroxydopa on catecholamine-containing neurons in brains of newborn rats. Brain Res 69(1):174–181
Kostrzewa R, Jacobowitz D (1972) The effect of 6-hydroxydopa on peripheral adrenergic neurons. J Pharmacol Exp Ther 183(2):284–297
Kostrzewa R, Jacobwitz D (1973) Acute effects of 6-hydroxydopa on central monoaminergic neurons. Eur J Pharmacol 21(1):70–80
Kostrzewa RM, Kostrzewa FP (2012) Neonatal 6-hydroxydopamine lesioning enhances quinpirole-induced vertical jumping in rats that were quinpirole primed during postnatal ontogeny. Neurotox Res 21(2):231–235
Kostrzewa RM, Brus R, Kalbfleisch J (1991) Ontogenetic homologous sensitization to the antinociceptive action of quinpirole in rats. Eur J Pharmacol 209:157–161
Kostrzewa RM, Gong L, Brus R (1992) Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiol Exp 53:31–41
Kostrzewa RM, Brus R, Rykaczewska M, Plech A (1993a) Low dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol Biochem Behav 44:487–489
Kostrzewa RM, Guo J, Kostrzewa FP (1993b) Ontogenetic quinpirole treatments induce vertical jumping activity in rats. Eur J Pharmacol 239:183–187
Kostrzewa RM, Brus R, Kalbflesich JH, Perry KW, Fuller RW (1994) Proposed animal model of attention deficit hyperactivity disorder. Brain Res Bull 34:161–167
Kostrzewa RM, Reader TA, Descarries L (1998) Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain. J Neurochem 70:889–898
Kostrzewa RM, Kostrzewa JP, Brus R (2000) Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids 19:183–199
Kostrzewa RM, Kostrzewa JP, Brus R (2002) Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson’s disease. Amino Acids 23:57–63
Kostrzewa RM, Kostrzewa JP, Brus R (2003) Dopamine receptor supersensitivity: an outcome and index of neurotoxicity. Neurotox Res 5:111–118
Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R (2004) Dopamine D2 agonist priming in intact and dopamine-lesioned rats. Neurotox Res 6:457–462
Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R (2005) Peculiarities of L-DOPA treatment of Parkinson’s disease. Amino Acids 28:157–164
Kostrzewa RM, Kostrzewa JP, Brus R, Kostrzewa RA, Nowak P (2006) Proposed animal model of severe Parkinson’s disease: neonatal 6-hydroxydopamine lesion of dopaminergic innervation of striatum. J Neural Transm Suppl 70:277–279
Kostrzewa RM, Huang N-Y, Kostrzewa JP, Nowak P, Brus R (2007) Modeling tardive dyskinesia: predictive 5-HT2C receptor antagonist treatment. Neurotox Res 11(1):41–50
Kostrzewa RM, Kostrzewa JP, Kostrzewa RA, Nowak P, Brus R (2008) Pharmacological models of ADHD. J Neural Transm 115(2):287–298
Kostrzewa RM, Kostrzewa JP, Kostrzewa RA, Kostrzewa FP, Brus R, Nowak P (2011) Stereotypic progressions in psychotic behavior. Neurotox Res 19:243–252
Kostrzewa JP, Kostrzewa RA, Kostrzewa RM, Brus R, Nowak P (2016a) Perinatal 6-hydroxydopamine modeling of ADHD. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Kostrzewa JP, Kostrzewa RA, Kostrzewa RM, Brus R, Nowak P (2016b) Perinatal 6-hydroxydopamine to produce a lifelong model of severe Parkinson’s disease. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Kostrzewa RM, Nowak P, Brus R, Brown RW (2016c) Perinatal treatments with the dopamine D2-receptor agonist quinpirole produces permanent D2-receptor supersensitization: a model of schizophrenia. Neurochem Res 2015 Nov 7. [Epub ahead of print] PMID: 26547196 In press
Krasnova IN, Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379–407
Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Bérard A (2011) Antiepileptic drug use during pregnancy: perinatal outcomes. Seizure 20(9):667–672
Lahiri DK, Maloney B, Zawia NH (2009) The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 14(11):992–1003
Laviola G, Adriani W, Rea M, Aloe L, Alleva E (2004) Social withdrawal, neophobia, and stereotyped behavior in developing rats exposed to neonatal asphyxia. Psychopharmacology 175:196–205
Le Magueresse C, Monyer H (2013) GABAergic interneurons shape the functional maturation of the cortex. Neuron 77(3):388–405
Leanza G, Nilsson OG, Wiley RG, Björklund A (1995) Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur J Neurosci 7(2):329–343
Leanza G, Nilsson OG, Nikkhah G, Wiley RG, Björklund A (1996) Effects of neonatal lesions of the basal forebrain cholinergic system by 192 immunoglobulin G-saporin: biochemical, behavioural and morphological characterization. Neuroscience 74(1):119–141
Lemaire V, Koehl M, Le Moal M, Abrous DN (2000) Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 97(20):11032–11037
Levy SE, Mandell DS, Schultz RT (2009) Autism. Lancet 374(9701):1627–1638
Lian H, Zheng H (2015) Signaling pathways regulating neuron glia interaction and their implications in Alzheimer’s disease. J Neurochem. 6 Nov 2015. doi:10.1111/jnc.13424. [Epub ahead of print] Review
Lloyd KA (2013) A scientific review: mechanisms of valproate-mediated teratogenesis. Bioscience Horizons 6:hzt003
Lyons WE, Fritschy JM, Grzanna R (1989) The noradrenergic neurotoxin DSP-4 eliminates the coeruleospinal projection but spares projections of the A5 and A7 groups to the ventral horn of the rat spinal cord. J Neurosci 9:1481–1489
Maccari S, Darnaudery M, Morley-Fletcher S, Zuena AR, Cinque C, Van Reeth O (2003) Prenatal stress and long-term consequences: implications of glucocorticoid hormones. Neurosci Biobehav Rev 27:119–127
Malinová-Ševčíková M, Hrebíčková I, Macúchová E, Nová E, Pometlová M, Šlamberová R (2014) Differences in maternal behavior and development of their pups depend on the time of methamphetamine exposure during gestation period. Physiol Res 63(Suppl 4):S559–S572
Maple AM, Perna MK, Parlaman JP, Stanwood GD, Brown RW (2007) Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex. Eur J Neurosci 26(9):2532–2538
Maple AM, Smith KJ, Perna MK, Brown RW (2015) Neonatal quinpirole treatment produces prepulse inhibition deficits in adult male and female rats. Pharmacol Biochem Behav 137:93–100
Marco EM, Velarde E, Llorente R, Laviola G (2016) Disrupted circadian rhythm as a common player in developmental models of neuropsychiatric disorders. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
McDonnell-Dowling K, Kelly JP (2015) The consequences of prenatal and/or postnatal methamphetamine exposure on neonatal development and behaviour in rat offspring. Int J Dev Neurosci 47(Pt B):147–156
Meier TB, Drevets WC, Wurfel BE, Ford BN, Morris HM, Victor TA, Bodurka J, Kent Teague T, Dantzer R, Savitz J (2015) Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder. Brain Behav Immun pii: S0889-1591(15) 30048-30049
Miller FD, Kaplan DR (2001) Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 58:1045–1053
Mizuno M, Kawamura H, Takei N, Nawa H (2008) The anthraquinone derivative emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia. J Neural Transm 115(3):521–530
Mizuno M, Kawamura H, Ishizuka Y, Sotoyama H, Nawa H (2010) The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats. Pharmacol Biochem Behav 97(2):392–398
Mohl B, Ofen N, Jones LL, Robin AL, Rosenberg DR, Diwadkar VA, Casey JE, Stanley JA (2015) Neural dysfunction in ADHD with reading disability during a word rhyming continuous performance task. Brain Cogn 99:1–7
Monden Y, Dan I, Nagashima M, Dan H, Uga M, Ikeda T, Tsuzuki D, Kyutoku Y, Gunji Y, Hirano D, Taniguchi T, Shimoizumi H, Watanabe E, Yamagata T (2015) Individual classification of ADHD children by right prefrontal hemodynamic responses during a go/no-go task as assessed by fNIRS. Neuroimage Clin 9:1–12
Mossakowski AA, Pohlan J, Bremer D, Lindquist R, Millward JM, Bock M, Pollok K, Mothes R, Viohl L, Radbruch M, Gerhard J, Bellmann-Strobl J, Behrens J, Infante-Duarte C, Mähler A, Boschmann M, Rinnenthal JL, Füchtemeier M, Herz J, Pache FC, Bardua M, Priller J, Hauser AE, Paul F, Niesner R, Radbruch H (2015) Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation. Acta Neuropathol 130(6):799–814
Mouton M, Harvey BH, Cockeran M, Brink CB (2015) The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression. Metab Brain Dis 18 Nov 2015 [Epub ahead of print]
Müller N, Weidinger E, Leitner B, Schwarz MJ (2015) The role of inflammation in schizophrenia. Front Neurosci 9:372
Myint AM (2013) Inflammation, neurotoxins and psychiatric disorders. Mod Trends Pharmacopsychiatri 28:61–74
Nagano T, Mizuno M, Morita K, Nawa H (2016) Pathological implications of oxidative stress in patients and animal models with schizophrenia: the role of epidermal growth factor receptor signaling. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizoguchi H, Yoneda Y (2009) Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Biol Pharm Bull 32(9):1576–1583
Narita N, Kato M, Tazoe M, Miyazaki K, Narita M, Okado N (2002) Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr Res 52(4):576–579
Neill JC, Harte MK, Haddad PM, Lydall ES, Dwyer DM (2014) Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans. Eur Neuropsychopharmacol 24(5):822–835
Niewiadomska G, Baksalerska-Pazera M, Riedel G (2009) The septo-hippocampal system, learning and recovery of function. Prog Neuropsychopharmacol Biol Psychiatry 33:791–805
Nowak P (2016) Selective lifelong destruction of brain monoaminergic nerves through perinatal DSP-4 treatment. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Nowak P, Brus R, Kostrzewa RM (2001) Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol J Pharmacol 53:319–329
Nowak P, Kostrzewa RM, Kwięcinski A, Bortel A, Łabus L, Brus R (2005) Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine. J Physiol Pharmacol 56(2):325–333
Nowak P, Bortel A, Dąbrowska J, Oświęcimska J, Drosik M, Kwieciński A, Opara J, Kostrzewa RM, Brus R (2007) Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. Neurotox Res 11(2):131–144
Nowak P, Kostrzewa RA, Skaba D, Kostrzewa RM (2010) Acute L-DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of Parkinsonian rats. Neurotox Res 17(3):299–304
Ong HH, Creveling CR, Daly JW (1969) The synthesis of 2,4,5-trihydroxyphenylalanine (6-hydroxydopa). A centrally active norepinephrine-depleting agent. J Med Chem 12(3):458–462
Ornoy A, Weinstein-Fudim L, Ergaz Z (2015) Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol 56:155–169
Oswiecimska J, Brus R, Szkilnik R, Nowak P, Kostrzewa RM (2000) 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats. Pharmacol Biochem Behav 67(1):11–15
Papadeas ST, Breese GR (2014) 6-Hydroxydopamine lesioning of dopamine neurons in neonatal and adult rats induces age-dependent consequences. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 133–198. ISBN 978-1-4614-5835-7 (print); ISBN 978-1-4614-5836-4 (eBook); ISBN 978-1-4614-7458-6 (print and electronic bundle). doi:10.1007/978-1-4614-5836-4_59
Pappas BA, Davidson CM, Fortin T, Nallathamby S, Park GA, Mohr E, Wiley RG (1996) 192 IgG-saporin lesion of basal forebrain cholinergic neurons in neonatal rats. Brain Res Dev Brain Res 96(1–2):52–61
Pappas BA, Payne KB, Fortin T, Sherren N (2005) Neonatal lesion of forebrain cholinergic neurons: further characterization of behavioral effects and permanency. Neuroscience 133(2):485–492
Pariante CM (2015) Neuroscience, mental health and the immune system: overcoming the brain-mind-body trichotomy. Epidemiol Psychiatr Sci 27:1–5
Paterak J, Stefański R (2014) 5,6- and 5,7-dihydroxytryptamines as serotoninergic neurotoxins. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 299–325. ISBN 978-1-4614-5835-7 (print); ISBN 978-1-4614-5836-4 (eBook); ISBN 978-1-4614-7458-6 (print and electronic bundle). doi:10.1007/978-1-4614-5836-4_76
Pekny M, Wilhelmsson U, Pekna M (2014) The dual role of astrocyte activation and reactive gliosis. Neurosci Lett 565:30–38
Pelly L, Vardy C, Fernandez B, Newhook LA, Chafe R (2015) Incidence and cohort prevalence for autism spectrum disorders in the Avalon Peninsula, Newfoundland and Labrador. CMAJ Open 3(3):E276–E280. doi:10.9778/cmajo.20140056
Perez SE, He B, Nadeem M, Wuu J, Scheff SW, Abrahamson EE, Ikonomovic MD, Mufson EJ (2015) Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer’s disease. Biol Psychiatry 77(8):693–703
Pérez-Gómez A, Tasker A (2014) Domoic acid as a neurotoxin. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 399–419. ISBN 978-1-4614-5835-7 (print); ISBN 978-1-4614-5836-4 (eBook); ISBN 978-1-4614-7458-6 (print and electronic bundle). doi:10.1007/978-1-4614-5836-4_87
Perna MK, Brown RW (2013) Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity. Behav Brain Res 242:102–109
Petrosini L, De Bartolo P, Tutuli D (2014) Neurotoxic effects, mechanisms and outcome of 192-IgG saporin. In: Kostrzewa RM (ed) Handbook of neurotoxicity. Springer, New York, pp 591–609. ISBN 978-1-4614-5835-7 (print); ISBN 978-1-4614-5836-4 (eBook); ISBN 978-1-4614-7458-6 (print and electronic bundle). doi:10.1007/978-1-4614-5836-4_79
Petrosini L, De Bartolo P, Cutuli D, Gelfo F (2016) Perinatal IgG saporin as neuroteratogen. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Phiel CJ, Zhang F, Huang EY, Guenther MG, Mitchell AL, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276:36734–36741
Pyndt Jørgensen B, Krych L, Pedersen TB, Plath N, Redrobe JP, Hansen AK, Nielsen DS, Pedersen CS, Larsen C, Sørensen DB (2015) Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia. Physiol Behav 141:32–39
Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281–294
Radonjić NV, Knezević ID, Vilimanovich U, Kravić-Stevović T, Marina LV, Nikolić T, Todorović V, Bumbasirević V, Petronijević ND (2010) Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration. Neuropharmacology 58(4–5):739–745
Radonjić NV, Jakovcevski I, Bumbaširević V, Petronijević ND (2013) Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1. Psychopharmacology 227(4):673–683
Ranger P, Ellenbroek BA (2016) Perinatal influences of valproate on brain and behavior: an animal model for autism. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Reynolds GP, Abdul-Monim Z, Neill JC, Zhang ZJ (2004) Calcium binding protein markers of GABA deficits in schizophrenia—postmortem studies and animal models. Neurotox Res 6(1):57–61
Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY (1982) Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235(1):93–103
Ricceri L, Calamandrei G, Berger-Sweeney J (1997) Different effects of postnatal day 1 versus 7 192 immunoglobulin G-saporin lesions on learning, exploratory behaviors, and neurochemistry in juvenile rats. Behav Neurosci 111(6):1292–1302
Ricceri L, Hohmann C, Berger-Sweeney J (2002) Early neonatal 192 IgG saporin induces learning impairments and disrupts cortical morphogenesis in rats. Brain Res 954(2):160–172
Ricceri L, Cutuli D, Venerosi A, Scattoni ML, Calamandrei G (2007) Neonatal basal forebrain cholinergic hypofunction affects ultrasonic vocalizations and fear conditioning responses in preweaning rats. Behav Brain Res 183(1):111–117
Robertson RT, Gallardo KA, Claytor KJ, Ha DH, Ku KH, Yu BP, Lauterborn JC, Wiley RG, Yu J, Gall CM, Leslie FM (1998) Neonatal treatment with 192 IgG-saporin produces long-term forebrain cholinergic deficits and reduces dendritic branching and spine density of neocortical pyramidal neurons. Cereb Cortex 8(2):142–155
Rodier PM, Ingram JL, Tisdale B, Croog VJ (1997) Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 11(2–3):417-422. Review
Rodriguez M, Rodriguez-Sabate C, Morales I, Sanchez A, Sabate M (2015) Parkinson’s disease as a result of aging. Aging Cell 14(3):293–308
Roman-Urrestarazu A, Lindholm P, Moilanen I, Kiviniemi V, Miettunen J, Jääskeläinen E, Mäki P, Hurtig T, Ebeling H, Barnett JH, Nikkinen J, Suckling J, Jones PB, Veijola J, Murray GK (2015) Brain structural deficits and working memory fMRI dysfunction in young adults who were diagnosed with ADHD in adolescence. Eur Child Adolesc Psychiatry 26 Aug 2015. [Epub ahead of print]
Roos A, Kwiatkowski MA, Fouche JP, Narr KL, Thomas KG, Stein DJ, Donald KA (2015) White matter integrity and cognitive performance in children with prenatalmethamphetamine exposure. Behav Brain Res 279:62–67
Rosenberg PA, Loring R, Xie Y, Zaleskas V, Aizenman E (1991) 2,4,5-trihydroxyphenylalanine in solution forms a non-N-methyl-D-aspartate glutamatergic agonist and neurotoxin. Proc Natl Acad Sci USA 88(11):4865–4869
Ross SB, Renyi AL (1976) On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) on the active uptake of noradrenaline. J Pharm Pharmacol 28:458–459
Ross SB, Stenfors C (1915) DSP4, a selective neurotoxin for the locus coeruleus noradrenergic system. A review of its mode of action. Neurotox Res 27(1):15–30. Review
Ross SB, Johansson JG, Lindborg B, Dahlbom R (1973) Cyclizing compounds. I. Tertiary N-(2-bromobenzyl)-N-haloalkylamines with adrenergic blocking action. Acta Pharm Sueccica 10:29–42
Roullet FI, Lai JK, Foster JA (2013) In utero exposure to valproic acid and autism–a current review of clinical and animal studies. Neurotoxicol Teratol 36:47–56. Review
Ruan L, Kang Z, Pei G, Le Y (2009) Amyloid deposition and inflammation in APPswe/PSIde9 mouse model of Alzheimer’s disease. Curr Alz Res 6:531–540
Sabers A, Bertelsen FC, Scheel-Krüger J, Nyengaard JR, Møller A (2015) Corrigendum to “Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain” [Neurosci.Lett. 580 (2014) 12–16] A possible new animal model of autism. Neurosci Lett 588:203–207
Sachs C, Jonsson G (1972a) Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA. J Neurochem 19(6):1561–1575
Sachs C, Jonsson G (1972b) Selective 6-hydroxy-DOPA induced degeneration of central and peripheral noradrenaline neurons. Brain Res 40(2):563–568
Sachs C, Jonsson G, Fuxe K (1973) Mapping of central noradrenaline pathways with 6-hydroxy-DOPA. Brain Res 63:249–261
Sakai M, Kashiwahara M, Kakita A, Nawa H (2014) An attempt of non-human primate modeling of schizophrenia with neonatal challenges of epidermal growth factor. J Addict Res Ther 5:1
Salavert J, Ramos-Quiroga JA, Moreno-Alcázar A, Caseras X, Palomar G, Radua J, Bosch R, Salvador R, McKenna PJ, Casas M, Pomarol-Clotet E (2015) Functional imaging changes in the medial prefrontal cortex in adult ADHD. J Atten Disord 2015 Oct 29. pii: 1087054715611492. [Epub ahead of print]
Sanders JD, Happe HK, Bylund DB, Murrin LC (2011) Changes in postnatal norepinephrine alter alpha-2 adrenergic receptor development. Neuroscience 192:761–772
Scattoni ML, Calamandrei G, Ricceri L (2003) Neonatal cholinergic lesions and development of exploration upon administration of the GABAa receptor agonist muscimol in preweaning rats. Pharmacol Biochem Behav 76(2):213–221
Schroeder SR, Oster-Granite ML, Berkson G, Bodfish JW, Breese GR, Cataldo MF, Cook EH, Crnic LS, DeLeon I, Fisher W, Harris JC, Horner RH, Iwata B, Jinnah HA, King BH, Lauder JM, Lewis MH, Newell K, Nyhan WL, Rojahn J, Sackett GP, Sandman C, Symons F, Tessel RE, Thompson T, Wong DF (2001) Self-injurious behavior: gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev 7(1):3–12
Sealey LA, Hughes BW, Steinemann A, Pestaner JP, Gene Pace D, Bagasra O (2015) Environmental factors may contribute to autism development and male bias: Effects of fragrances on developing neurons. Environ Res 142:731–738
Seiden LS, Fischman MW, Schuster CR (1976) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend 1:215–219
Shaywitz BA, Klopper JH, Yager RD, Gordon JW (1976a) Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine. Nature 261(5556):153–155
Shaywitz BA, Yager RD, Klopper JH (1976b) Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191(4224):305–308
Siniscalco D (2015) Commentary: the impact of neuroimmune alterations in autism spectrum disorder. Front Psychiatry 6:145
Sircar R (2003) Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-D-aspartate receptor upregulation. Int J Dev Neurosci 21(3):159–167
Sitte HH, Freissmuth M (2010) The reverse operation of Na+/Cl−-coupled neurotransmitter transporters—why amphetamines take two to tango. J Neurochem 112:340–355
Šlamberová R, Vrajová M, Schutová B, Mertlová M, Macúchová E, Nohejlová K, Hrubá L, Puskarčíková J, Bubeníková-Valešová V, Yamamotová A (2014) Prenatal methamphetamine exposure induces long-lasting alterations in memory and development of NMDA receptors in the hippocampus. Physiol Res 63(Suppl 4):S547–S558
Šlamberová R, Pometlová M, Macúchová E, Nohejlová K, Stuchlík A, Valeš K (2015) Do the effects of prenatal exposure and acute treatment of methamphetamineon anxiety vary depending on the animal model used? Behav Brain Res 292:361–369
Smith LM, Diaz S, LaGasse LL, Wouldes T, Derauf C, Newman E, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM (2015) Developmental and behavioral consequences of prenatal methamphetamineexposure: a review of the Infant Development, Environment, and Lifestyle (IDEAL) study. Neurotoxicol Teratol 51:35–44
Snyder AM, Zigmond MJ, Lund RD (1986) Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J Comp Neurol 245(2):274–281
Soligo M, Protto V, Florenzano F, Bracci-Laudiero L, De Benedetti F, Chiaretti A, Manni L (2015) The mature/pro nerve growth factor ratio is decreased in the brain of diabetic rats: analysis by ELISA methods. Brain Res 1624:455–468
Sotoyama H, Zheng Y, Iwakura Y, Mizuno M, Aizawa M, Shcherbakova K, Wang R, Namba H, Nawa H (2011) Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF. PLoS One 6(10):e25831
Sotoyama H, Namba H, Chiken S, Nambu A, Nawa H (2013) Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling. J Neurochem 126(4):518–528
Steardo L Jr, Bronzuoli MR, Iacomino A, Esposito G, Steardo L, Scuderi C (2015) Does neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytes. Front Neurosci 9:259
Stojković T, Radonjić NV, Velimirović M, Jevtić G, Popović V, Doknić M, Petronijević ND (2012) Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 39(1):192–199
Sygnecka K, Heine C, Scherf N, Fasold M, Binder H, Scheller C, Franke H (2015) Nimodipine enhances neurite outgrowth in dopaminergic brain slice co-cultures. Int J Dev Neurosci 40:1–11
Takuma K, Hara Y, Kataoka S, Kawanai T, Maeda Y, Watanabe R, Takano E, Hayata-Takano A, Hashimoto H, Ago Y, Matsuda T (2014) Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism. Pharmacol Biochem Behav 126:43–49
Tan L, Yu JT, Tan L (2012) The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. J Neurol Sci 323(1–2):1–8
Tartaglione AM, Venerosi A, Calamandrei G (2016) Anna Maria Tartaglione1,2, Aldina Venerosi 1, Gemma Calamandrei1Early life toxic insults and onset of sporadic neurodegenerative diseases. an overview of experimental studies. In: Kostrzewa RM, Archer T (eds) Neurotoxin modeling of brain disorders-lifelong outcomes in behavioral teratology. Springer, New York
Tasker RA, Strain SM, Drejer J (1996) Selective reduction in domoic acid toxicity in vivo by a novel non-N-methyl-D-aspartate receptor antagonist. Can J Physiol Pharmacol 74:1047–1054
Teitelbaum J (1990) Acute manifestations of domoic acid poisoning: case presentations. Can Dis Wkly Rep 16:5–6
Terranova JP, Chabot C, Barnouin MC, Perrault G, Depoortere R, Griebel G, Scatton B (2005) SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology 181(1):134–144
Thacker SK, Perna MK, Ward JJ, Schaefer TL, Williams MT, Kostrzewa RM, Brown RW (2006) The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. Eur J Neurosci 24(7):2075–2083
Thoenen H, Tranzer JP (1968a) Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 261(3):271–288
Thoenen H, Tranzer JP (1968b) [On the possibility of chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine (6-OH-DA)]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 260(2):212–213. German
Tizabi Y, Copeland RL Jr, Brus R, Kostrzewa RM (1999) Nicotine blocks quinpirole-induced behavior in rats: psychiatric implications. Psychopharmacol 145:433–441
Tohmi M, Tsuda N, Mizuno M, Takei N, Frankland PW, Nawa H (2005) Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. Behav Genet 35(5):615–629
Tohyama M, Maeda T, Kashiba A, Shimizu N (1974a) Fluorescence and electron microscopic analysis of axonal change of coerulo-cortical noradrenaline neuron system following destruction of locus coeruleus and administration of 6-hydroxydopa in the rat brain. Med J Osaka Univ 24(4):205–221
Tohyama M, Maeda T, Shimizu N (1974b) Detailed noradrenaline pathways of locus coeruleus neuron to the cerebral cortex with use of 6-hydroxydopa. Brain Res 79(1):139–144
Tuszynski MH, Blesch A (2004) Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer’s disease. Prog Brain Res 146:441–449
Uchida H, Sakata H, Fujimura M, Niizuma K, Kushida Y, Dezawa M, Tominaga T (2015) Experimental model of small subcortical infarcts in mice with long-lasting functional disabilities. Brain Res 1629:318–328
Uhrbrand A, Stenager E, Pedersen MS, Dalgas U (2015) Parkinson’s disease and intensive exercise therapy—a systematic review and meta-analysis of randomized controlled trials. J Neurol Sci 353(1–2):9–19
Ungerstedt U (1968) 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 5(1):107–110
Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69–93
Verdoorn TA, Johansen TH, Drejer J, Nielsen EO (1994) Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur J Pharmacol 269:43–49
Verkhratsky A, Parpura V, Pekna M, Pekny M, Sofroniew M (2015) Glia in the pathogenesis of neurodegerative disease. Biochem Soc Trans 42(5):1291–1301
Vieira AC, Aleman N, Cifuentes JM, Bermudez R, Lopez Pena M, Botana LM (2015) Brain pathology in adult rats treated with domoic acid. Veterinary Pathol 52:1077–1086
Visser JE, Smith DW, Moy SS, Breese GR, Friedmann T, Rothstein JD, Jinnah HA (2001) Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res Dev Brain Res 133(2):127–139
Vorhees CV, Ahrens KG, Acuff-Smith KD, Schilling MA, Fisher JE (1994a) Methamphetamine exposure during early postnatal development in rats: I. Acoustic startle augmentation and spatial learning deficits. Psychopharmacology 114(3):392–401
Vorhees CV, Ahrens KG, Acuff-Smith KD, Schilling MA, Fisher JE (1994b) Methamphetamine exposure during early postnatal development in rats: II. Hypoactivity and altered responses to pharmacological challenge. Psychopharmacology 114(3):402–408
Vorhees CV, Skelton MR, Grace CE, Schaefer TL, Graham DL, Braun AA, Williams MT (2009) Effects of (+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Int J Dev Neurosci 27(3):289–298
Vrajová M, Schutová B, Klaschka J, Stěpánková H, Rípová D, Šlamberová R (2014) Age-related differences in NMDA receptor subunits of prenatallymethamphetamine-exposed male rats. Neurochem Res 39(11):2040–2046
Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101:431–447
Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532
Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ (1995) 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience 65(2):463–476
Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM (2001) Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107(4):535–550
Wang Y, Musich PR, Serrano MA, Zou Y, Zhang J, Zhu MY (2014) Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y cells. Neurotox Res 25(2):193–207
Weinstock M (2008) The long-term behavioural consequences of prenatal stress. Neurosci Biobehav Rev 32:1073–1086
Wenk GL, Stoehr JD, Quintana G, Mobley S, Wiley RG (1994) Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J Neurosci 14(10):5986–5995
White IM, Minamoto T, Odell JR, Mayhorn J, White W (2009) Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats. Brain Res 1266:72–86
Wingate M, Kirby RS, Pettygrove S, Cunniff C, Schulz E, Ghosh T, Robinson C, Lee LC, Landa R, Constantino J, Fitzgerald R, Zahorodny W, Daniels J, Nicholas J, Charles J, McMahon W, Bilder D, Durkin M, Baio J, Christensen D, Braun KV, Clayton H, Goodman A, Doernberg N, Yeargin-Allsopp M, Lott E, Mancilla KC, Hudson A, Kast K, Jolly K, Chang A, Harrington R, Fitzgerald R, Shenouda J, Bell P, Kingsbury C, Bakian A, Henderson A, Arneson C, Washington A, Frenkel G, Wright V (2014) Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ. 63(2):1–21
Winn LM, Wells PG (1999) Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Radic Biol Med 26(3–4):266–274
Wischhof L, Irrsack E, Osorio C, Koch M (2015) Prenatal LPS-exposure—a neurodevelopmental rat model of schizophrenia—differentially affects cognitive functions, myelination, and parvalbumin expression in male and female offspring. Prog Neuropsychopharmacol Biol Psychiatry 57:17–30
Wong DF, Harris JC, Naidu S, Yokoi F, Marenco S, Dannals RF, Ravert HT, Yaster M, Evans A, Rousset O, Bryan RN, Gjedde A, Kuhar MJ, Breese GR (1996) Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci USA 93(11):5539–5543
Xi D, Peng YG, Ramsdell JS (1997) Domoic acid is a potent neurotoxin to neonatal rats. Nat Toxins 5:74–79
Xia Y, Qi F, Zou J, Yang J, Yao Z (2014) Influenza vaccination during early pregnancy contributes to neurogenesis and behavioral function in offspring. Brain Behav Immun 42:212–221
Zelazo PD, Carlson SM (2012) Hot and cool executive function in childhood and adolescence: development and plasticity. Child Devel Perspec. doi:10.1111/j.1750-8606.2012.00246.x
Zelazo PD, Müller U, Frye D, Marcovitch S, Argitis G, Boseovski J, Chiang JK, Hongwanishkul D, Schuster BV, Sutherland A (2003) The development of executive function in early childhood. Monogr Soc Res Child Dev 68(3):vii–137
Zelazo PD, Craik FI, Booth L (2004) Executive function across the life span. Acta Psychol 115(2–3):167–183
Zhu F, Zheng Y, Ding YQ, Liu Y, Zhang X, Wu R, Guo X, Zhao J (2014a) Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of liposaccharide in rats. PLoS One 9(4):e93966
Zhu F, Zhang L, Ding YQ, Zhao J, Zheng Y (2014b) Neonatal intrahippocampal injection of liposaccharide induces deficits in social behavior and prepulse inhibition and microgial activation in rats: implication for a new schizophrenia animal model. Brain Behav Immun 38:166–174
Zieher LM, Jaim-Etcheverry G (1973) Regional differences in the long-term effect of neonatal 6-hydroxydopa treatment on rat brain noradrenaline. Brain Res 60(1):199–207
Zieher LM, Jaim-Etcheverry G (1975a) 6-hydroxydopa during development of central adrenergic neurons produces different long-term changes in rat brain noradrenaline. Brain Res 86(2):271–281
Zieher LM, Jaim-Etcheverry G (1975b) Different alterations in the development of the noradrenergic innervation of the cerebellum and the brain stem produced by neonatal 6-hydroxydopa. Life Sci 17(6):987–991
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Archer, T., Kostrzewa, R.M. (2015). Neuroteratology and Animal Modeling of Brain Disorders. In: Kostrzewa, R.M., Archer, T. (eds) Neurotoxin Modeling of Brain Disorders—Life-long Outcomes in Behavioral Teratology. Current Topics in Behavioral Neurosciences, vol 29. Springer, Cham. https://doi.org/10.1007/7854_2015_434
Download citation
DOI: https://doi.org/10.1007/7854_2015_434
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34134-7
Online ISBN: 978-3-319-34136-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)